ANAPTYSBIO INC (ANAB)
US0327241065 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 63.18M -15.76% | 10.29M -83.71% | 17.157M 66.73% | 57.25M 233.68% | 35.774M -37.51% | 47.793M 33.60% | 52.043M 8.89% | 104.62M 101.03% | 237.25M 126.77% | 477.05M 101.07% | 744.5M 56.06% | |
| EBITDA YoY % growth | -56.19M -140.95% | -114.47M -103.72% | -156.42M -36.65% | -153M 2.19% | -219.3M -43.33% | -173.91M 20.70% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -56.81M -137.90% | -115.15M -102.69% | -157.072M -36.41% | -152.49M 2.92% | -209.228M -37.21% | -234.19M -11.93% | -297.851M -27.18% | -312.27M -4.84% | -217.27M 30.42% | 18.726M 108.62% | 376.23M 1,909.13% | |
| Operating Margin | -89.92% | -1,119.05% | -915.50% | -266.36% | -584.86% | -490.01% | -572.32% | -298.48% | -91.58% | 3.93% | 50.53% | |
| EPS YoY % growth | -2.05 -169.74% | -4.57 -122.93% | -6.08 -33.04% | -6.21 -2.21% | -5.86 5.70% | -5.52 5.81% | -9.43 -70.88% | -8.10 14.17% | -3.95 51.20% | 1.85 146.73% | 15.76 753.59% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.59 -0.31% | -1.93 -17.64% | -1.54 10.02% | -1.58 -38.17% | -1.47 7.63% | -1.33 30.98% | -1.37 10.78% | -1.42 10.02% | -1.53 -3.79% | -1.54 -15.36% | -1.57 -14.34% | -1.67 -17.74% |
| Revenue Q2Q % growth | 7.934M -11.89% | 7.684M 7.03% | 7.905M -27.95% | 8.313M -72.31% | 8.534M 7.56% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -45.9M -34.43% | 57.436M 236.63% | 53.621M 234.04% | 53.213M 338.67% | 42.269M 192.09% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -45.544M -30.89% | -66.533M -57.66% | -51.159M -26.88% | -52.835M -132.17% | -54.975M -20.71% | -67.507M -1.46% | -70.883M -38.55% | -74.426M -40.86% | -81.093M -47.51% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.14 19.15% | -1.68 | 0.54 | 32.14% |
| Q2 2024 Q2Q % growth | -1.71 -14.00% | -1.01 | -0.70 | -69.51% |
| Q1 2024 Q2Q % growth | -1.64 -3.80% | -1.60 | -0.04 | -2.69% |
| Q4 2023 Q2Q % growth | -1.59 -70.97% | -1.63 | 0.04 | 2.65% |
| Q3 2023 Q2Q % growth | -1.41 -19.49% | -1.83 | 0.42 | 22.95% |
| Q2 2023 Q2Q % growth | -1.50 -30.43% | -1.73 | 0.23 | 13.36% |
| Q1 2023 Q2Q % growth | -1.58 -20.61% | -1.07 | -0.51 | -47.81% |
| Q4 2022 Q2Q % growth | -0.93 17.70% | -0.98 | 0.05 | 4.74% |
| Q3 2022 Q2Q % growth | -1.18 -391.67% | -0.74 | -0.44 | -59.94% |
| Q2 2022 Q2Q % growth | -1.15 -5,650.00% | -1.04 | -0.11 | -10.35% |
| Q1 2022 Q2Q % growth | -1.31 -98.48% | -1.01 | -0.30 | -29.08% |
| Q4 2021 Q2Q % growth | -1.13 -194.17% | 2.62 | -3.75 | -143.06% |
| Q3 2021 Q2Q % growth | -0.24 72.41% | -0.93 | 0.69 | 74.10% |
| Q2 2021 Q2Q % growth | -0.02 97.47% | -0.11 | 0.09 | 81.70% |
| Q1 2021 Q2Q % growth | -0.66 -120.00% | -0.70 | 0.04 | 5.95% |
| Q4 2020 Q2Q % growth | 1.20 260.00% | 1.42 | -0.22 | -15.48% |
| Q3 2020 Q2Q % growth | -0.87 24.35% | -0.74 | -0.13 | -18.25% |
| Q2 2020 Q2Q % growth | -0.79 11.24% | -0.76 | -0.03 | -3.29% |
| Q1 2020 Q2Q % growth | -0.30 63.41% | -0.64 | 0.34 | 53.31% |
| Q4 2019 Q2Q % growth | -0.75 -17.19% | -1.22 | 0.47 | 38.54% |
| Q3 2019 Q2Q % growth | -1.15 -74.24% | -1.17 | 0.02 | 1.82% |
| Q2 2019 Q2Q % growth | -0.89 -56.14% | -1.01 | 0.12 | 11.61% |
| Q1 2019 Q2Q % growth | -0.82 -30.16% | -0.84 | 0.02 | 2.64% |
| Q4 2018 Q2Q % growth | -0.64 | -0.93 | 0.29 | 31.52% |
| Q3 2018 Q2Q % growth | -0.66 | -0.72 | 0.06 | 8.67% |
| Q2 2018 Q2Q % growth | -0.57 | -0.71 | 0.14 | 19.73% |
| Q1 2018 Q2Q % growth | -0.63 | -0.43 | -0.20 | -44.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 30.017M 804.67% | 7.01M | 23.007M | 328.20% |
| Q2 2024 Q2Q % growth | 10.971M 217.08% | 24.787M | -13.816M | -55.74% |
| Q1 2024 Q2Q % growth | 7.179M 422.49% | 4.047M | 3.132M | 77.39% |
| Q4 2023 Q2Q % growth | 9.005M 32.23% | 2.273M | 6.732M | 296.17% |
| Q3 2023 Q2Q % growth | 3.318M 157.21% | 2.481M | 837K | 33.74% |
| Q2 2023 Q2Q % growth | 3.46M 183.61% | 3.388M | 72K | 2.13% |
| Q1 2023 Q2Q % growth | 1.374M 41.65% | 3.647M | -2.273M | -62.33% |
| Q4 2022 Q2Q % growth | 6.81M 574.26% | 6.967M | -157K | -2.25% |
| Q3 2022 Q2Q % growth | 1.29M -93.82% | 10.55M | -9.26M | -87.77% |
| Q2 2022 Q2Q % growth | 1.22M -95.94% | 4.808M | -3.588M | -74.63% |
| Q1 2022 Q2Q % growth | 970K -91.38% | 5.155M | -4.185M | -81.18% |
| Q4 2021 Q2Q % growth | 1.01M -98.32% | 113.1M | -112.09M | -99.11% |
| Q3 2021 Q2Q % growth | 20.89M | 6.808M | 14.082M | 206.84% |
| Q2 2021 Q2Q % growth | 30.03M | 29.459M | 571K | 1.94% |
| Q1 2021 Q2Q % growth | 11.25M -25.00% | 9.577M | 1.673M | 17.47% |
| Q4 2020 Q2Q % growth | 60M 1,900.00% | 65.28M | -5.28M | -8.09% |
| Q3 2020 Q2Q % growth | 1.7M | -1.7M | -100.00% | |
| Q2 2020 Q2Q % growth | -100.00% | 2.368M | -2.368M | -100.00% |
| Q1 2020 Q2Q % growth | 15M | 6.375M | 8.625M | 135.29% |
| Q4 2019 Q2Q % growth | 3M | 2.04M | 960K | 47.06% |
| Q3 2019 Q2Q % growth | -100.00% | 3.173M | -3.173M | -100.00% |
| Q4 2018 Q2Q % growth | 1.199M | -1.199M | -100.00% | |
| Q3 2018 Q2Q % growth | 5M | 255K | 4.745M | 1,860.78% |
| Q2 2018 Q2Q % growth | 663K | -663K | -100.00% | |
| Q1 2018 Q2Q % growth | 1.071M | -1.071M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 3.87% | 0.8% | 8.82% |
| Revenue | -0.25% | 72.85% | 8.52% | 74.89% |